Shijiazhuang Yiling Pharmaceutical Hits Day Low Amid Price Pressure at CNY 14.91

Shijiazhuang Yiling Pharmaceutical Co., Ltd. experienced a notable decline today, with the stock dropping by 3.47% and reaching an intraday low of CNY 14.91. This performance contrasts with the China Shanghai Composite, which saw a modest gain of 0.5% on the same day. Over the past week, Shijiazhuang Yiling has decreased by 2.85%, while the broader market index fell by 0.29%. In the month leading up to this decline, the stock has lost 7.52%, significantly underperforming the Shanghai Composite's increase of 0.63%. Year-to-date, Shijiazhuang Yiling's performance is down 12.13%, compared to the index's gain of 3.16%. Despite these recent challenges, the company reported a robust net profit growth of 42.92% in its latest quarterly results, marking positive outcomes for three consecutive quarters. Additionally, the company has achieved its highest operating cash flow at CNY 2,055.74 million and a return on capital employed of 12.48%. The decline in raw material costs by 16.65% year-over-year may also provide some operational relief moving forward.